Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
2.350
+0.190 (8.80%)
Jan 7, 2025, 4:00 PM EST - Market closed
Allogene Therapeutics Analyst Ratings
Total Analysts
12
Consensus Rating
Buy
Price Target
$10.06
Upside
+328.09%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $11 → $9 | Buy | Maintains | $11 → $9 | +282.98% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +282.98% | Nov 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +282.98% | Oct 30, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +282.98% | Aug 15, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +240.43% | Aug 9, 2024 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $17 → $14 | Strong Buy | Reiterates | $17 → $14 | +495.74% | Aug 9, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $13 → $11 | Buy | Initiates | $13 → $11 | +368.09% | Aug 8, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $35 → $14 | Strong Buy | Maintains | $35 → $14 | +495.74% | Aug 8, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $11 | Buy | Initiates | $11 | +368.09% | May 31, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $14 → $13 | Buy | Maintains | $14 → $13 | +453.19% | May 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $9 | Strong Buy | Maintains | $10 → $9 | +282.98% | May 16, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $17 | Strong Buy | Maintains | $17 | +623.40% | May 15, 2024 |
| Stifel | Stifel | Hold Maintains $4.4 → $4.6 | Hold | Maintains | $4.4 → $4.6 | +95.74% | May 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +325.53% | Mar 19, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $10 | Buy | Reiterates | $10 | +325.53% | Mar 15, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $9 → $8 | Buy | Maintains | $9 → $8 | +240.43% | Feb 27, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.